RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity

PHASE3CompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

December 30, 2015

Primary Completion Date

December 14, 2017

Study Completion Date

December 14, 2017

Conditions
Retinopathy of Prematurity
Interventions
DRUG

Ranibizumab

Administered as an intravitreal injection

PROCEDURE

Laser therapy

Transpupillary diode or frequency-doubled yttrium aluminum garnet (YAG) laser ablative therapy, following anesthesia or sedation

Trial Locations (86)

1090

Novartis Investigative Site, Vienna

1125

Novartis Investigative Site, Budapest

2100

Novartis Investigative Site, Koebenhavn Ø

4032

Novartis Investigative Site, Debrecen

8000

Novartis Investigative Site, Bruges

9000

Novartis Investigative Site, Ghent

10000

Novartis Investigative Site, Zagreb

10002

Novartis Investigative Site, Taipei

11211

Novartis Investigative Site, Riyadh

12808

Novartis Investigative Site, Prague

13419

Novartis Investigative Site, Tallinn

13915

Novartis Investigative Site, Marseille

14642

Novartis Investigative Site, Rochester

14700

Novartis Investigative Site, Praha 4 - Podoli

21131

Novartis Investigative Site, Alexandria

21201

Novartis Investigative Site, Baltimore

26480

Novartis Investigative Site, Eskişehir

26506

Novartis Investigative Site, Morgantown

30625

Novartis Investigative Site, Hanover

31000

Novartis Investigative Site, Osijek

33305

Novartis Investigative Site, Taoyuan District

34140

Novartis Investigative Site, Istanbul

34147

Novartis Investigative Site, Zuhuratbaba / Istanbul

40208

Novartis Investigative Site, Louisville

48105

Novartis Investigative Site, Ann Arbor

50139

Novartis Investigative Site, Florence

50586

Novartis Investigative Site, Kuala Lumpur

53127

Novartis Investigative Site, Bonn

60612

Novartis Investigative Site, Chicago

76090

Novartis Investigative Site, Querataro

78705

Novartis Investigative Site, Austin

80045

Novartis Investigative Site, Aurora

80054

Novartis Investigative Site, Amiens

84132

Novartis Investigative Site, Salt Lake City

88996

Novartis Investigative Site, Kota Kinabalu

92354

Novartis Investigative Site, Loma Linda

95817

Novartis Investigative Site, Sacramento

110029

Novartis Investigative Site, New Delhi

127486

Novartis Investigative Site, Moscow

194100

Novartis Investigative Site, Saint Petersburg

300041

Novartis Investigative Site, Timișoara

380016

Novartis Investigative Site, Ahmedabad

420012

Novartis Investigative Site, Kazan'

428028

Novartis Investigative Site, Cheboksary

500025

Novartis Investigative Site, Brasov

625020

Novartis Investigative Site, Madurai

641014

Novartis Investigative Site, Coimbatore

695035

Novartis Investigative Site, Vanchiyoor

02111

Novartis Investigative Site, Boston

A-8036

Novartis Investigative Site, Graz

708 52

Novartis Investigative Site, Ostrava Poruba

115 27

Novartis Investigative Site, Ampelokipoi

Novartis Investigative Site, Goudi- Athens

546 29

Novartis Investigative Site, Thessaloniki

400 008

Novartis Investigative Site, Mumbai

00168

Novartis Investigative Site, Rome

06100

Novartis Investigative Site, Perugia

Novartis Investigative Site, Ankara

00054

Novartis Investigative Site, Fiumicino

453-8511

Novartis Investigative Site, Nagoya

466 8560

Novartis Investigative Site, Nagoya

276-8524

Novartis Investigative Site, Yachiyo

812-8582

Novartis Investigative Site, Fukuoka

814-0180

Novartis Investigative Site, Fukuoka

830-0011

Novartis Investigative Site, Kurume

960-1295

Novartis Investigative Site, Fukushima

Unknown

Novartis Investigative Site, Sapporo

765-8507

Novartis Investigative Site, Zentsujichó

901-1303

Novartis Investigative Site, Shimajiri-Gun

594-1101

Novartis Investigative Site, Izumi

520-2192

Novartis Investigative Site, Ohtsu-city

183-8561

Novartis Investigative Site, Fuchū

143 8541

Novartis Investigative Site, Ōta-ku

157-8535

Novartis Investigative Site, Setagaya-ku

130-8575

Novartis Investigative Site, Sumida-ku

170-8476

Novartis Investigative Site, Toshima-ku

LT-50161

Novartis Investigative Site, Kaunas

15-274

Novartis Investigative Site, Bialystok

51-124

Novartis Investigative Site, Wroclaw

020395

Novartis Investigative Site, Bucharest

833 40

Novartis Investigative Site, Bratislava

07100

Novartis Investigative Site, Soguksu / Antalya

06500

Novartis Investigative Site, Ankara

M13 9WL

Novartis Investigative Site, Manchester

OX3 9DU

Novartis Investigative Site, Oxford

PO6 3LY

Novartis Investigative Site, Portsmouth

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY